Revance Therapeutics, Inc. 

TN

  SEC # 1479290

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Relationships

        

No  Owner Relationships  (where the Issuers of the  Revance Therapeutics, Inc.-owned  securities are...)

        

First  20  of  94  Issuer Relationships  (where the Owners of the  Revance Therapeutics, Inc.  securities are...)

First		Latest Filing		Filing		Filer / Owner
		4/17/24		4		TN	Jordan Erica
12/7/15		4/9/24		SC 13G		NY	JPMorgan Chase & Co.
9/7/17		3/19/24		4		CA	Foley Mark J
2/19/20		3/19/24		4		CA	Moxie Dwight
11/7/18		3/19/24		4		CA	Schilke Tobin
12/17/19		3/19/24		4		CA	Sjuts Dustin S
3/9/23		3/18/24		144		CA	Moxie Dwight
3/9/23		3/18/24		144		CA	Schilke Tobin
3/9/23		3/18/24		144		CA	Sjuts Dustin S
		2/29/24		3		NC	Hollander David
		2/29/24		3		TN	Jordan Erica
2/14/23		2/14/24		SC 13G		NY	Antara Capital LP
2/14/22		2/14/24		SC 13G		CA	Palo Alto Investors LP
2/14/23		2/13/24		SC 13G			Polar Capital Holdings plc
2/10/22		2/13/24		SC 13G		PA	Vanguard Group Inc.
2/11/22		2/9/24		SC 13G		CA	Capital World Investors
3/13/20		2/9/24		SC 13G			GIC Private Ltd.
1/9/15		2/6/24		SC 13G		CA	Franklin Resources Inc.
1/28/16		1/25/24		SC 13G		NY	BlackRock Inc.
9/1/23		10/24/23		SC 13D			Teoxane SA
→Please Sign In to List all of them.

List all Money Managers that own this Security Issuer:  CUSIP 761330

        

First  20  of  56  Insider & Control Relationships  (Directors & Officers, Owners, Parent / Subs., et al.)

First		Latest Filing		Relationship		Registrant
2/29/24		4/17/24		Officer:  Chief Commercial Officer		TN	Jordan Erica
11/29/21		3/19/24		Officer:  CEO		CA	Foley Mark J
9/7/17		3/19/24		Director			"
3/4/24		3/19/24		Officer:  CLO & GC		CA	Moxie Dwight
11/7/18		3/19/24		Officer:  CFO		CA	Schilke Tobin
11/10/21		3/19/24		Officer:  President		CA	Sjuts Dustin S
		2/29/24		Officer:  CMO & Global Therapeutics Lead		NC	Hollander David
2/19/20		2/2/24		Officer:  SVP, GC & Secretary		CA	Moxie Dwight
3/2/21		6/20/23		Director		TN	Kolaja Carey OConnor
6/6/19		5/5/23		Director		CA	Beraud Jill
3/3/23		5/5/23		Director		CT	Coric Vlad
7/6/16		5/5/23		Director		CA	Gangolli Julian S
7/18/19		5/5/23		Director		CA	Nolet Chris
3/6/14		5/5/23		Director		CA	Russell Angus C.
3/10/21		5/5/23		Director		CA	Ware Olivia C
3/2/15		5/13/22		Director		CA	Vickers Philip J.
		3/17/22		Officer:  Chief Executive Officer		CA	Foley Mark J
3/17/20		3/17/22		Officer:  COO, President of R&D		CA	Joshi Abhay
7/27/20		3/17/22		Director		CA	Rankin Aubrey
		3/17/22		Officer:  Chief Financial Officer		CA	Schilke Tobin
→Please Sign In to List all of them.

        

No  Joint-Filer Relationships  (Co-Filer Registrants:  Partners, Affiliates, et al.)

        

No  Group-Member Relationships  (Co-Filer Non-Registrants:  Partners, Affiliates, et al.)

        

Filing Agent Relationships  (SEC Filing Agents, Attorneys, Printers, et al. — Affiliates:  Directors & Officers, et al.)

Revance Therapeutics, Inc.  has been the Filing Agent for  over 20  Affiliates:

Latest Filing						Most-Recent 20 Affiliates			Filings
		Type		As Party
4/17/24		4		Insider:³		TN	Jordan Erica		2
3/19/24		4		Insider:³		CA	Sjuts Dustin S		32
3/19/24		4		Insider:³		CA	Moxie Dwight		16
3/19/24		4		Insider:³		CA	Schilke Tobin		38
3/19/24		4		Insider:³		CA	Foley Mark J		25
2/29/24		3		Insider:³		NC	Hollander David		1
6/20/23		4		Insider:³		TN	Kolaja Carey OConnor		7
5/5/23		4		Insider:³		CA	Gangolli Julian S		7
5/5/23		4		Insider:³		CA	Ware Olivia C		6
5/5/23		4		Insider:³		CA	Nolet Chris		7
5/5/23		4		Insider:³		CA	Russell Angus C.		8
5/5/23		4		Insider:³		CT	Coric Vlad		3
5/5/23		4		Insider:³		CA	Beraud Jill		7
5/13/22		4/A		Insider:³		CA	Vickers Philip J.		7
2/17/22		4		Insider:³		CA	Joshi Abhay		17
12/6/21		4		Insider:³		CA	Rankin Aubrey		13
5/15/20		4		Insider:³		CA	Gardner Phyllis		4
5/15/20		4		Insider:³		CA	Byrnes Robert F		3
2/19/20		4		Insider:³		CA	McDowell Caryn Gordon		7
7/2/19		4		Insider:³		CA	Browne L Daniel		10
Total:									220
__________
³   Insider:  Filing by the Affiliate filed as a Director, Officer, 10% Owner and/or Other “insider” of the Registrant, who is an Issuer.

6  Filing Agents and/or Registrants have submitted Filings for  Revance Therapeutics, Inc.:

Latest Filing				Filing Agentª, Registrant or SEC — SEC #			Filings
		Type
3/21/24		DEFA14A			No Filing Agent:  Self-filed — 1479290		171
3/5/24		8-K		NY	Donnelley Financial Solutions/FA — 1193125		104
6/25/20		EFFECT			No Filing Agent:  SEC-filed by SEC #5 — 9999999995		6
2/27/20		SEC LETTER			No Filing Agent:  SEC-filed by SEC #7 — 9999999997		16
8/7/15		10-Q		IA	Workiva Inc. Wdesk FA01/FA — 1628280		12
11/5/13		DRS/A		NY	Donnelley Financial Solutions/FA — 950123		3
Total:							312
__________  ª  Proprietary to SEC Info℠:  The SEC does not publish the names of SEC Filing Agents.